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 A variety of antigens, including soluble proteins, viral-
encoded proteins, and minor histocompatibility antigens, elicit
a deviant systemic immune response when injected into the
anterior chamber (AC) of the eye. This immune deviation is
termed anterior chamber-associated immune deviation
(ACAID) [1,2]. It is characterized by impaired Ag-specific
delayed-type hypersensitivity (DTH), expanded clones of pre-
cursor cytotoxic T cells, and elevated serum levels of
noncomplement-fixing Abs [3]. During the induction of
ACAID, intraocular antigen-presenting cells capture the anti-
gen placed in the eye and carry it to the marginal zone of the
spleen. In the presence of thymus-derived natural killer T cells
and marginal zone B cells, a microenvironment capable of
activating antigen-specific T cells to differentiate into regula-
tory cells is created in the spleen. A number of studies have
demonstrated that there are two distinct populations of regu-
latory T cells (Tregs) involved in the suppression of DTH re-
sponses in ACAID [3-9]. One population comprises CD4+ T
cells, which block the induction or afferent component of the
immune response. Another population consists of CD8+ T cells,
which inhibit the expression of DTH through previously sen-
sitized T cells.
The crucial role of Tregs in the maintenance of immune
tolerance and in the control of autoimmunity has been inten-
sively investigated during the last decades. Up to now, several
markers, such as CD25 [10], GITR [11], CTLA-4 [12], and
LAG-3 [13], have been used to define Tregs. However, they
are also associated with the activation of T cells. Foxp3, a
kind of forkhead transcription factor encoded by the X chro-
mosome, has been considered a specific marker of Treg lin-
eage [14-20]. It is not upregulated in recently activated
CD4+CD25- T cells. Mice with a deficiency in Foxp3 show a
rapid, fatal lymphoproliferative autoimmune syndrome
[16,20]. Ectopic expression of Foxp3 can confer suppressor
activity on some nonregulatory T cells [15-17]. Since the great
majority of Foxp3-expressing cells are CD4+ T cells [14], most
studies have addressed the role of CD4+ Tregs in immune tol-
erance. More recently, the role of CD8+ Tregs during immune
tolerance has also been emphasized [21]. Increasing evidence
has indicated that CD8+ regulatory T cells can express Foxp3
in both humans and rodents [21-24]. The expression of Foxp3
on CD8+ T cells during ACAID is not well known and was,
therefore, the subject of our study. Here we show that splenic
CD8+ T cells from ACAID mice express Foxp3 after polyclonal
and specific antigen stimulation.
METHODS
Mice:  Specific pathogen-free female C57BL/6 (B6; H-2b), 6-
8-week-old mice were purchased from the animal facility at
the Sun Yat-Sen University, P.R. China. All mice were treated
according to the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. The numbers of mice used
in the various experiments are described below.
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Results: OVA injection into the AC induced ACAID, and CD8+ T cells from ACAID mice inhibited the ear-swelling
response by OVA-primed responder cells in LAT assay. Flow cytometry analysis showed that the frequency of CD8+Foxp3+
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968Reagents:  OVA was purchased from Sigma-Aldrich
(Steinheim, Germany) and dissolved in phosphate-buffered
saline (PBS). Complete Freund’s adjuvant (CFA) containing
heat-killed Mycobacterium tuberculosis strain H37Ra was
purchased from Sigma-Aldrich. The Abs used in flow
cytometry (FCM) were Fc blocker (affinity purified anti-mouse
CD16/32, clone 93), fluorescein isothiocyanate (FITC)-con-
jugated antimouse CD3e (clone 145-2C11), allophycocyanin
(APC)-conjugated antimouse/antirat Foxp3 staining set (clone
FJK-16s), and APC-conjugated rat IgG2a isotype control (all
purchased from eBioscience, San Diego, CA). Phycoeryth-
rin-Cy5.5 (PE-Cy5.5)-conjugated antimouse CD8a (clone
5H10) was purchased from Caltag Laboratories (Burlingame,
CA). FITC-conjugated antimouse F4/80 antigen (clone CI:A3)
was purchased from Serotec (Oxford, UK).
Treatment of mice:  ACAID was induced as described
previously using microinjection of antigen into the AC of the
eye [25]. Briefly, mice were anesthetized and 5 µl OVA (20
mg/ml) was injected into the AC by a glass micropipette with
a sterile infant feeding tube mounted onto a 0.1 ml Hamilton
(Hamilton, Reno, NV) syringe. Mice receiving an AC-injec-
tion of PBS served as a control (PBS-AC-injected mice).
Primed mice received a subcutaneous (SC) injection of 250
µg of OVA in PBS. To induce a DTH response, we gave the
mice soluble antigen emulsified 1:1 in CFA. Each animal re-
ceived a total volume of 200 µl antigen in CFA.
Impaired Ag-specific delayed-type hypersensitivity assay:
The ear-swelling response was measured to indicate DTH re-
sponse to OVA as described previously [26-28]. Both ear pin-
nae of ACAID mice and control animals were measured with
a Mitutoyo engineer’s micrometer (MTI Corp., Paramus, NJ)
immediately before challenge. In these experiments, primed
mice served as positive controls and untreated mice served as
negative controls. OVA (400 µg) in 20 µl PBS was injected
SC into the right ear pinnae. The left ear pinnae received 20 µl
sterile PBS alone. Both ears were measured 24 h later, and the
difference in thickness was used as a measurement of DTH.
Results were expressed as follows: specific ear swelling (24 h
measurement-0 h measurement) of the right ear (24 h mea-
surement-0 h measurement) of the left ear. Five mice were
used for each group through one experiment and the experi-
ment was repeated twice.
Preparation of peritoneal exudate cells:  Peritoneal exudates
cells (PECs) were harvested from C57BL/6 mice that had re-
ceived 2.5 ml of thioglycolate (Sigma-Aldrich) intraperito-
neally three days earlier. As described previously [29], the re-
covered cells were washed and resuspended, placed in 24-well
culture plates (1x106 cells/well), and incubated in complete
RPMI 1640 medium at 37 °C in an atmosphere of 5% CO2.
After overnight culture, plates were washed three times with
culture medium to remove nonadherent cells. Adherent cells
were retained in the wells and used as antigen-presenting cells
in subsequent experiments. To test the purity of the adherent
cells through FCM, we harvested these cells after incubation
on ice for 1 h and then gently removed them with a cell-lifter.
More than 90% of the adherent cells were identified as being
F4/80+ cells.
Cell isolation and culture:  Fourteen days after AC injec-
tion, single cell suspensions of splenocytes were prepared by
passing cells through a sterile wire mesh. Red blood cells in
spleens were lysed with Tris-NH4Cl or removed through den-
sity gradient centrifugation. In some experiments, the total
splenocyte population was cultured in complete RPMI 1640
medium with stimulation of anti-CD3 and anti-CD28 mAb or
with OVA for 36 h and used for FCM analysis of Foxp3 ex-
pression. These splenocytes were cultured in a density of 2x106
cells/ml in 24-well culture plates. The volume was 1 ml for
each well. CD8+ T cells were isolated from splenocytes, using
magnetic separation columns (MiniMACS, MS columns;
Miltenyi Biotec, Bergisch-Gladbach, Germany) according to
the manufacturer’s instructions. After positive selection, the
purity of CD8+ T cells was >95% according to subsequent
FCM analysis. The purified CD8+ T cells were then cultured
in 24-well culture plates (2x106 cells/well) containing isolated
PECs with 200 µg/ml of OVA at 37 °C in complete RPMI
1640 medium for 36 h and used for RT-PCR analysis of Foxp3
expression.
Local adoptive transfer assay:  A local adoptive transfer
(LAT) assay was developed to test suppressor cells during
ACAID [30,31]. Putative suppressor cells consisting of puri-
fied CD8+ T cells were separated from splenocytes of AC-
injected mice. Immune cells were collected from splenocytes
of primed mice. Both suppressor cells and immune cells were
harvested on day 14 after injection and were suspended at 5x107
cells/ml in 10 mg/ml OVA in PBS. The immune and suppres-
sor cells populations were then mixed 1:1 in the presence of
antigen (10 mg/ml). Both ears of naïve C57BL/6 mice were
measured with an engineer’s micrometer immediately before
challenge. The right ear pinnae of naïve C57BL/6 mice were
injected with 20 µl (1x106 cells) of the mixed-cell population.
The left ear pinnae were injected with 10 mg/ml of OVA in
PBS (negative control). Ear swelling was measured 24 h later
to evaluate DTH. Naïve T cells from nonmanipulated mice
were used as immune cells and purified CD8+ T cells from
these mice were used as suppressor cells for negative con-
trols. Primed T cells were used as immune cells, and CD8+ T
cells were purified from nonmanipulated mice and used as
suppressor cells for positive controls. In one experiment, two
ACAID mice and three normal mice were used to generate
putative suppressor cells, and one primed mouse was used to
generate immune cells. Five naïve mice were used for mea-
suring the ear-swelling response for each group in one experi-
ment. The experiment was repeated twice.
Flow cytometry:  Analysis of Foxp3 protein expression
in stimulated or unstimulated splenocytes from normal,
ACAID, and PBS-AC-injected mice was performed with BD
FACSAria (BD Biosciences, San Jose, CA) using the BD
FACSDiVa software (BD Biosciences). Cells were prepared
according to the manufacturer’s instructions using the
antimouse/rat Foxp3 staining set. Briefly, 1x106 cells were first
stained with FITC-CD3e mAb and Pecy5.5-CD8a mAb at 4
°C for 30 min, then fixed and permeabilized using fixation/
permeabilization buffer at 4 °C for 2 h. Cells were washed in
permeabilization buffer and then incubated with Fc blocker
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969for 15 min. The cells were not washed prior to being incu-
bated with APC-Foxp3 at 4 °C for another 30 min. After wash-
ing, the cells were resuspended and subjected to FCM. Cells
stained with APC-conjugated rat IgG2a served as isotype con-
trols. In vitro, the cells stimulated with BSA served as irrel-
evant antigen controls. Four mice were used for each group in
one experiment. These experiments were repeated twice.
Reverse transcription-PCR:  Total cellular RNA was iso-
lated from 5x106 purified CD8+ cells with or without stimula-
tion using Trizol (Invitrogen, San Diego, CA). The total amount
of RNA was reverse transcribed using Superscript III reverse-
transcriptase (Invitrogen) and oligo(dT) primer (Tiangen,
Beijing, China) in a final volume of 20 µl. First strand cDNA
(1.0 µl) was amplified in a 25 µl reaction using Taq Platinum
PCR MasterMix (Tiangen). β-Actin was used as a control.
For Foxp3 amplification, PCR reactions consisted of a 3 min
denaturation step at 94 °C followed by 40 cycles of 30 s at 94
°C, 1 min at 48 °C, and 30 s at 72 °C. For β-actin, reactions
were conducted as described above except that the annealing
temperature was 54 °C for 30 s and the number of cycles was
30. The following primers were used: Foxp3-FW, 5'-CCC AGG
AAA GAC AGC AAC CTT-3'; Foxp3-RV, 5'-CCT TGC CTT
TCT CAT CCA GGA-3'; β-actin-FW, 5'-GTC CCT CAC CCT
CCC AAA AG-3'; and β-actin-RV, 5'-GCT GCC TCA ACA
CCT CAA CCC-3'. Spleen cells from two mice were used in
each group in one experiment. The experiment was repeated
twice.
Statistics:  Statistical analyses were performed by one-
way ANOVA using SPSS 11.0. A p<0.05 was considered sig-
nificant.
RESULTS
Local adoptively transferred CD8+ T cells from anterior
chamber-associated immune deviation mice are able to in-
hibit the Ag-specific delayed-type hypersensitivity response
in naïve recipients:  As reported by others [26] and documented
in our group’s earlier work [27,28], ACAID was successfully
induced by AC injection of OVA. The LAT assay was used to
study the inhibitory function of antigen-specific efferent sup-
pressor cells in ACAID. In this experiment, CD8+ T cells were
purified, mixed with responder cells and finally transferred in
the presence of OVA to the ear pinnae of naïve animals. The
ear-swelling responses of mice that received responder cells
mixed with CD8+ cells from normal mice displayed signifi-
cant ear swelling indicative of a DTH response (positive con-
trol). However, this ear-swelling response induced by re-
sponder cells was significantly reduced when CD8+ cells from
ACAID mice were coinjected with these cells. The result of a
typical experiment is shown in Figure 1.
The frequency of CD8+ T cells is increased in the spleen
of anterior chamber-associated immune deviation mice:  FCM
was used to examine the frequency of CD8+ T cells in
splenocytes harvested 14 days after an AC injection of OVA.
The results showed that the frequency of CD8+ T cells from
the spleen of ACAID mice was 42.5% of the CD3+ gated sple-
nocyte population, which was significantly higher than that
from normal mice (37.7%, p=0.043) and PBS-AC-injected
mice (37.8%, p=0.034; Figure 2). There was no significant
difference between the normal mice and the PBS-AC-injected
mice (p=0.969).
CD8+ cells from anterior chamber-associated immune de-
viation mice express increased Foxp3 protein upon activation:
FCM was employed to examine Foxp3 expression in CD8+
splenocytes during ACAID production. As shown in Figure 3,
the frequency of CD8+Foxp3+ T cells was 0.35%, 0.35%, and
0.30%, respectively, in the CD8+ splenocytes from ACAID
mice, normal mice, and PBS-AC-injected mice, none of whom
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Figure 1. Effect of CD8+ T cells from anterior chamber-associated
immune deviation mice on the expression of impaired Ag-specific
delayed type hypersensitivity in vivo.  Purified CD8+ T cells from
splenocytes were used as regulator cells. Regulator cells and ovalbu-
min (OVA)-primed responder cells were prepared 14 days after anti-
gen injection. The regulator cells and responder cells were mixed 1:1
in the presence of OVA and transferred to the ear pinnae of naïve
C57BL/6 mice. As a negative control, naïve spleen cells were used
as responder cells and purified CD8+ T cells from untreated mice
were used as regulatory cells. Primed spleen cells were used as re-
sponder cells, and purified CD8+ T cells from untreated mice were
used as regulatory cells for a positive control. Ear swelling was mea-
sured at 24 h. Mean±SEM ear-swelling responses are presented (n=5).
The asterisk indicates a p<0.05, and NS denotes a p>0.05. The ex-
periments were repeated twice with similar results.
Figure 2. Flow cytometry analysis of CD8+ T cells in different groups.
Anterior chamber-associated immune deviation (ACAID) group re-
ceived an anterior chamber (AC) injection of ovalbumin (OVA). The
phosphate-buffered saline-anterior chamber (PBS-AC) group received
an AC injection of PBS. We gated on CD3+ T cells, and the frequency
of CD8+ T cells is shown on the vertical axis. Results represent the
mean±SEM of two separate experiments. The asterisk indicates a
p<0.05.
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Figure 3. Flow cytometry analy-
sis of Foxp3 protein expression in
CD8+ T cells from normal mice,
anterior chamber-associated im-
mune deviation mice, and phos-
phate-buffered saline-anterior
chamber-injected mice without
stimulation or with specific or non-
specific stimulation.  Whole spleen
cells were obtained from C57BL/
6 mice 14 days after anterior
chamber (AC) injection. Intracel-
lular staining of Foxp3 is shown
in gated CD8+ cells from anterior
chamber-associated immune de-
viation (ACAID) mice, phosphate-
buffered saline-anterior chamber
(PBS-AC)-injected mice and nor-
mal mice. In the ACAID group,
the mice received an AC injection
of 5 µl ovalbumin (OVA; 20 mg/
ml). PBS-AC-injected mice re-
ceived an AC injection of 5 µl
PBS. A: Representative data show-
ing the expression of Foxp3 on
CD8+ splenocytes from normal,
ACAID, and PBS-AC-injected
mice following polyclonal stimu-
lation. B: Representative data
showing the expression of Foxp3
on CD8+ splenocytes from normal,
ACAID, and PBS-AC-injected
mice after stimulation with OVA
or BSA control. C: The statistic
histogram for the frequencies of
CD8+Foxp3+ cells in different
groups with or without stimula-
tion. Results represent the
mean±SEM of two separate ex-
periments. The double asterisk in-
dicates a p<0.01, and NS denotes
a p>0.05.
971received stimulation. There were no significant differences
among these three groups. We further assayed the frequency
of CD8+Foxp3+ T cells in different groups after in vitro stimu-
lation either with anti-CD3 plus anti-CD28 or with OVA (Fig-
ure 3). The results showed that the frequency of CD8+Foxp3+
T cells in the spleen of normal mice was significantly increased
after polyclonal stimulation (0.35% versus 1.14%; p<0.001),
but only slightly after OVA stimulation (0.35% versus 0.44%;
p=0.297). A similar result was also observed in the spleen of
PBS-AC-injected mice (0.30% versus 1.30%; p<0.001 in
polyclonal stimulation; 0.30% versus 0.36%; p=0.436 in OVA
stimulation). The frequencies of CD8+Foxp3+ T cells were both
increased significantly in ACAID mice after stimulation with
either anti-CD3 plus anti-CD28 mAb (0.35% versus 2.90%;
p<0.001) or OVA (0.35% versus 1.58%; p<0.001) in vitro.
The frequency of CD8+Foxp3+ T cells were significantly higher
in ACAID mice than that in normal mice (2.90% versus 1.14%;
p=0.009 in non-specific stimulation; 1.58% versus 0.44%;
p=0.005 in specific stimulation) and in PBS-AC-injected mice
after both stimulations (2.90% versus 1.30%; p=0.012 in non-
specific stimulation; 1.58% versus 0.36%; p=0.004 in specific
stimulation).
Expression of Foxp3 mRNA is found in CD8+ T cells from
anterior chamber-associated immune deviation mice after
polyclonal stimulation:  As expression of certain molecules at
the protein level and the mRNA level is not always identical,
we analyzed the Foxp3 mRNA expression in CD8+ splenocytes
during ACAID by RT-PCR. As shown in Figure 4, Foxp3
mRNA was not detectable in CD8+ T cells from OVA-stimu-
lated and unstimulated ACAID mice, normal mice, or PBS-
AC-injected mice. However, the expression of Foxp3 mRNA
was noted in CD8+ T cells from ACAID mice after stimula-
tion with anti-CD3 plus anti-CD28 mAb. It remained unde-
tectable in CD8+ T cells from normal mice and PBS-AC-in-
jected mice. Sequence analysis with the relative primers war-
ranted the RT-PCR products of Foxp3.
DISCUSSION
 In this study, we showed that an injection of OVA into the AC
of the murine eye could induce ACAID and that the splenic
CD8+ T cells from ACAID mice were able to inhibit the DTH
response. The expression of Foxp3 protein in the splenic CD8+
T cells in ACAID was increased after stimulation with anti-
CD3 plus anti-CD28 mAb or specific antigen in vitro. The
Foxp3 mRNA was also upregulated in CD8+ T cells in ACAID
after polyclonal stimulation. These results suggest that expres-
sion of Foxp3 may be a property of efferent CD8+ Tregs in
ACAID.
It has been shown that CD8+ Tregs are necessary for in-
hibiting the expression of DTH in ACAID [5,6]. However,
the phenotype of this population remains unclear. For the pur-
pose of studying the phenotype of these Tregs, we first inves-
tigated the frequency of CD8+ T cells in the spleen. Our study
revealed that the frequency of CD8+ T cells was increased sig-
nificantly in the spleen of ACAID mice. This result is consis-
tent not only with expanded clones of precursor cytotoxic T
cells [3], one feature of ACAID, but also with the findings
presented by McKenna and colleagues [32]. They found that
injection of soluble antigen into the AC of the eye induced
expansion of antigen-specific CD8+ T cells. A further study
using a LAT assay was performed to determine the suppres-
sive property of this population. The result showed that CD8+
T cells in the spleen of ACAID mice could inhibit the ear swell-
ing of naïve mice produced by primed T cells. This result in-
dicated that efferent suppressor cells were present in the CD8+
T cell population residing in the spleen of ACAID mice.
Since Foxp3 has been generally considered to be a spe-
cific marker for Tregs both in rodents and humans in spite of
CD4 or CD8 lineage [14], a study was performed to examine
the expression of Foxp3 in CD8+ T cells at both the mRNA
level and protein level during ACAID. The results showed
that an upregulated expression of Foxp3 in CD8+ T cells could
only be shown at both the mRNA level and protein level when
cells were stimulated using polyclonal activation. These re-
sults suggest that a subset of CD8+Foxp3+ T cells were in-
duced in the ACAID mice and that these T cells were detect-
able only after stimulation. It was interesting to note that the
expression of Foxp3 was up-regulated at the protein level, but
not at mRNA level, after specific (OVA) stimulation. A sig-
nificantly higher expression of Foxp3 protein was also ob-
served with polyclonal stimulation than with specific stimu-
lation. The reasons for a discrepancy between mRNA expres-
sion and protein expression after specific stimulation are not
fully understood. One explanation is that posttranscriptional
control mechanisms may be important for Foxp3 protein ex-
pression. This discrepancy was also found in a study by
Fontenot et al. [16], who demonstrated that Foxp3 protein
expression, but not Foxp3 mRNA expression, was increased
following an in vitro activation of naturally existing
CD4+CD25+ Tregs. It is also possible that the findings reflect
a difference in sensitivity of the Foxp3 protein versus the
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Figure 4. Reverse transcription-PCR analysis of Foxp3 expression
in CD8+ T cells from normal mice, anterior chamber-associated im-
mune deviation mice, and phosphate-buffered saline-anterior cham-
ber-injected mice without stimulation or with specific or nonspecific
stimulation.  As a control, β-actin was amplified from the same RNA
sample. Lane 1: normal mice without stimulation; lane 2: ACAID
mice without stimulation; lane 3: PBS-AC-injected mice without
stimulation; lane 4: normal mice stimulated with OVA; lane 5: ACAID
mice stimulated with OVA; lane 6: PBS-AC-injected mice stimu-
lated with OVA; lane 7: normal mice stimulated with anti-CD3 plus
anti-CD28; lane 8: ACAID mice stimulated with anti-CD3 plus anti-
CD28; lane 9: PBS-AC-injected mice stimulated with anti-CD3 plus
anti-CD28; lane 10: DNA marker. Results are representative of two
independent experiments.
972mRNA signal. The aforementioned result also suggested that
polyclonal stimulation was stronger than specific antigen
stimulation in promoting the expression of Foxp3 in both
ACAID mice and normal mice using FCM. This result was
consistent with the findings by Fontenot et al. [16]. They found
the expression of Foxp3 to be associated with the strength of
TCR signals during thymic selection.
In order to exclude the influence produced by AC-injec-
tion, we performed a study using mice receiving an AC-injec-
tion of PBS as a control. The result showed that there was no
difference between stimulated and unstimulated PBS-AC-in-
jected control mice and normal mice concerning the expres-
sion of Foxp3 in CD8+ T cells. This finding suggests that the
increased expression of Foxp3 in ACAID is an intrinsic fea-
ture of this type of immune tolerance and not a concomitant
phenomenon merely induced by AC-injection.
It is interesting to note that the frequency of CD8+Foxp3+
T cells in ACAID mice was only about 2% even after
polyclonal stimulation. This is contrary to a much higher fre-
quency of Foxp3 in CD4+CD25+ Tregs in ACAID mice (up to
90% in a study in our laboratory [33]). The wild-type mice
used in this study may have affected the lower frequency. In
these wild-type mice, the great majority of Foxp3-expressing
cells are CD4+, but not CD8+, T cells [14]. A previous study
from our laboratory found that the frequency of CD8+ cells
specific to OVA in wild-type mice was very low [28]. In “OVA
T cell receptor” transgenic mice, the frequency of CD8+Foxp3+
T cells can be expected to be much higher. Sasaki and col-
leagues [34] found that the expression of Foxp3 was almost
88% in CD8+ T cells from such transgenic mice when these T
cells were exposed to TGF-β2-treated OVA-pulsed APC in
vitro.
Foxp3 expression in CD8+ T cells has also been reported
in another immune tolerance model in lupus-prone mice. Hahn
et al. [21] injected artificial peptide intravenously into these
mice and found induction of Foxp3-expressing CD8+ T cells.
Functional studies showed that these CD8+ T cells suppressed
anti-DNA IgG production both in vitro and in vivo. These re-
sults, together with ours, suggested that the increased expres-
sion of Foxp3 in CD8+ Tregs may play a role in the expression
of immune tolerance induced either via the AC of the eye or
the intravenous route.
Our study has revealed an increased expression of Foxp3
in the CD8+ T cells in ACAID mice. To play a role in the
inhibition of the DTH response one would expect these cells
to express IL-10 and TGF-β. Since the population of these
cells is low in ACAID mice, it is currently not yet possible to
assay the production of these cytokines. Further resolution of
this issue awaits the development of more sensitive techniques.
Alternatively, TCR transgenic mice, which have been shown
to have numerous CD8+Foxp3+ T cells, may be suitable for
the aforementioned cytokine analysis. A direct role for
CD8+Foxp3+ T in the induction of ACAID has not yet been
proven by the data presented by our study. At present we have
not succeeded in isolating sufficient numbers of CD8+Foxp3+
T cells. Other techniques, such as the use of SiRNA for Foxp3,
may be used in future experiments to block the function of
these cells and definitely prove their role in ACAID.
There are at least two functionally distinct types of Tregs
involved in the development of ACAID. They exert a sup-
pressive function during different phases of ACAID. The af-
ferent regulatory cells are CD4+, and the efferent regulatory
cells are CD8+. A recent study by Keino et al. [35] showed the
expression of Foxp3 in the CD4+CD25+ ACAID Tregs. We
confirmed these findings and moreover showed that the fre-
quency of CD4+Foxp3+ T cells was higher in ACAID mice
than in normal mice [33]. However, the exact mechanisms
whereby CD4+Foxp3+ T cells mediate ACAID have however
not yet been clarified. Since both CD4+ and CD8+ T cells ex-
pressing Foxp3 play a role in ACAID, it is interesting to find
out which Foxp3+ T cell population is indispensable or whether
both populations are needed for the development of ACAID.
In conclusion, our study revealed an inhibitory effect of
CD8+ T cells on the expression of the DTH response and an
increased expression of Foxp3+ on CD8+ T cells in an OVA-
induced ACAID model. These results suggest that CD8+Foxp3+
T cells may play a role in the development of ACAID. How-
ever, the exact role of this subpopulation of cells in ACAID
requires further investigation.
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